Study on MK-2010 Alone and With Other Treatments for Advanced Solid Tumors
Sponsor: Merck Sharp & Dohme LLC
ClinicalTrials ID:NCT07793942
This clinical trial is exploring a new medicine called MK-2010, used alone or with other treatments, to see if it can help treat advanced solid tumors. These are cancers that have spread and cannot be removed by surgery. The study aims to find out if MK-2010 is safe and effective in shrinking or eliminating tumors.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
Researchers are testing a new treatment called MK-2010 for advanced solid tumors, which are cancers that have spread and cannot be surgically removed. The study will evaluate if MK-2010, used alone or with other treatments, can help the immune system fight cancer. The main goals are to determine the safety of MK-2010 and how well patients tolerate it, as well as to see if the treatment can shrink or eliminate tumors.
Eligibility Criteria
Inclusion Criteria
- Have a type of cancer that can be measured by scans or tests.
- Be able to swallow pills if the treatment is taken by mouth and have no digestive issues that affect absorption.
- Have well-controlled HIV if diagnosed, with ongoing antiretroviral therapy.
- Have good organ function as required by the study.
Exclusion Criteria
- Have a history of certain diseases like Kaposi's sarcoma or Multicentric Castleman's Disease if diagnosed with HIV.
- Have a history of brain conditions like posterior reversible encephalopathy syndrome or seizures.
- Have severe liver conditions or diseases affecting the brain due to liver issues.
- Have inflammatory bowel disease.
- Have serious wounds, ulcers, or bone fractures that are not healing.
- Have a history of heart inflammation or heart muscle disease.
- Have severe heart or blood vessel diseases.
- Be taking blood thinners.
- Have an immune system deficiency.
- Have another cancer that is growing or needed treatment in the last 3 years.
- Have cancer that has spread to the brain or spinal cord.
- Have an active autoimmune disease needing treatment in the last 2 years (except for hormone treatments like thyroxine or insulin).
- Have a history of lung inflammation needing steroids or current lung disease.
- Have had a stem cell or organ transplant.
- Have not fully recovered from major surgery or have ongoing surgical issues.
Locations
| FACILITY | ZIP | CITY | STATE |
|---|---|---|---|
| New Jersey Cancer Care ( Site 7002) | 07109 | Belleville | New Jersey |
| START Astera, LLC ( Site 0220) | 08816 | East Brunswick | New Jersey |
| Taylor Cancer Research Center ( Site 9500) | 43537 | Maumee | Ohio |
| Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) ( Site 8001) | 97401 | Eugene | Oregon |
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.
